Neurology ReviewsNIH and FDA Release a Draft Clinical Trial Protocol Template for Public Discussion April 20, 2016
Clinical Neurology NewsSmall study: OTC antihistamine shows potential as a remyelinating agent in MSApril 20, 2016Multiple Sclerosis
Clinical Neurology NewsUnitedHealth Group leaving most ACA marketplacesApril 19, 2016Business of Medicine
Neurology ReviewsAAN Updates Guidelines on Use of Botulinum Toxin for Four DisordersApril 19, 2016Headache & MigraineMovement DisordersParkinson's Disease
Clinical Neurology NewsNew data help guide the stopping of disease-modifying drugs in MSApril 19, 2016Multiple Sclerosis
Clinical Neurology NewsAAN updates botulinum toxin guidelines for most established usesApril 19, 2016StrokeMultiple SclerosisMovement DisordersNeuromuscular DisordersPain
Neurology ReviewsTargeting T and B Cells as a Therapeutic Approach for Multiple SclerosisApril 18, 2016
Clinical Neurology NewsAnti-CGRP agent delivered durable episodic migraine preventionApril 18, 2016Pain
